RxDoctor Payments Data

Ashley Greiner

Gerontology · Mt Pleasant, IANPI 1194183756

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Novo Nordisk at 32.0% of the total. That places this record below the midpoint for gerontology clinicians in IA, where the typical reported total is $242.

$242in general payments, 2019–2025

Across 14 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$78
  • Pfizer$40
  • Exact Sciences$33
  • Integra Lifesciences Corporation$20
  • AbbVie$17
  • Dexcom, Inc.$15
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$242 in reported general payments places this provider in the 50th percentile of 28 gerontology providers in Iowa.

See all gerontology providers in Iowa

Medicare billing

Part B allowed, 2024
$13,746
Medicare patients
96
Services billed
926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban105$50,605
OzempicSemaglutide32$35,751
JardianceEmpagliflozin11$12,560
XareltoRivaroxaban18$9,865
Tresiba Flextouch U-200Insulin Degludec15$6,799
JanuviaSitagliptin Phosphate17$5,669
Fentanyl72$5,087
EntrestoSacubitril/Valsartan11$3,626
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc38$3,595
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$3,478
Duloxetine Hcl83$3,146
Potassium Chloride130$3,044
Levothyroxine Sodium271$2,661
SymbicortBudesonide/Formoterol Fumarate11$2,580
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$2,046

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$40$50,605105 claims
Novo NordiskOzempic$78$35,75132 claims
MerckJanuvia$14$5,66917 claims
AstraZenecaSymbicort$13$2,58011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 28 gerontology providers in Iowa.

Other gerontology in Mt Pleasant

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →